The Impact of Multidisciplinary Discussion (MDD) in the Diagnosis and Management of Fibrotic Interstitial Lung Diseases

<table class="table-group" id="tab3"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td class="align_left">Provisional diagnosis (<i>n</i>)</td><td class="align_center">Effect on management (<i>n</i>)</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td class="align_left" rowspan="2">HP = 8</td><td class="align_center">Initiation pharmacological treatment (4)</td></tr><tr><td class="align_center">No change (4)</td></tr><tr><td class="align_left" colspan="2"><hr/></td></tr><tr><td class="align_left">IPF = 4</td><td class="align_center">No change (4)</td></tr><tr><td class="align_left" colspan="2"><hr/></td></tr><tr><td class="align_left" rowspan="2">NSIP = 3</td><td class="align_center">No change (2)</td></tr><tr><td class="align_center">Initiation pharmacological treatment (1)</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr><tr class="table-fn"><td><div>HP = hypersensitivity pneumonitis; IPF = idiopathic pulmonary fibrosis; NSIP = nonspecific interstitial pneumonia.<br/></div></td></tr></table>

<div>Provisional diagnoses and effect on management.</div>

Canadian Respiratory Journal

tab3

Table 3

Table 3: The Impact of Multidisciplinary Discussion (MDD) in the Diagnosis and Management of Fibrotic Interstitial Lung Diseases 